WHITE PAPERS & CASE STUDIES
What’s The Impact Of Big Data In The Cold Chain?
Anywhere you look these days, people talk about big data. Whether you are in the technology industry, the retail industry, the supply chain and logistics industry, or any other industry, there is no doubt that big data plays a part.
Precise Cold-Chain Logistics Supports Global Study Of Heart Disease
The challenge involved the precise cold storage temperatures (between 2-8°C) required to assure the integrity of the strips during the transfer and storage of the product to various sites around the globe.
The Urgent Need For Qualified Transportation Providers
Given the high cost of conducting global clinical trials and the even higher cost of failure, regulatory agencies and pharmaceutical companies alike now demand that every party involved in the pharmaceutical supply chain — transportation and logistics providers included — conform to GxP guidelines. By World Courier
"Safety First" In The Distribution Of Valuable Life Science Products
Remember the predictions of how email, video conferencing and the other now commonplace means of communication, would erode the need for so much air travel? I also remember how airlines created various loyalty programs targeted at maintaining their share of the business traveler market as promises of reduced travel for employees was just on the horizon. OK, so how well did you do in reducing your travel?
Protecting A Temperature-Critical Healing Innovation In Storage And Shipping
Mike Whitmore, ABH's logistics manager, explains that the company faced two challenges. First, it was running out of storage space; when operating at maximum capacity, the company can produce more than 300,000 units of Dermagraft per year. Second, keeping its entire inventory in one location posed a risk to the supply.
PRODUCTS & SERVICESMore Products & Services
LIFE SCIENCE WEBINARS
H.R. 3204 Drug Quality And Security Act
After so many years of struggling with how to comply with the California ePedigree requirement, we now need to know how to comply with the new federal requirement, H.R. 3204. This webinar will review DQSA requirements and timelines.
Top Things To Consider When Evaluating Your Vendor’s Security Of Supply Strategies
The biopharmaceutical industry’s increasingly complex global supply chains, often involving single-source supplier arrangements, are made vulnerable by uncertain financial environments and unpredictable natural disasters.
Successfully Managing The Risks And Challenges Of Orphan Drugs
Orphan drugs, while life changing and in many cases life saving for patients, are fraught with challenges for biotech and pharmaceutical manufacturers. These range from locating the patients and their physician caregivers, to making sure the patients can pay for these therapies, to the overcoming the numerous risk points in moving very expensive and in most cases temperature controlled goods to patients all over the globe. This webinar looks at addressing these issues. The experienced speakers will guide you through the salient points and considerations when dealing with these challenges.
The Cost of Failure In Pharma Development: A Risk for Everyone
Predicting potential problems serves no purpose if it is not accompanied by adequate corrective actions or mitigation strategies to address them. This webinar will also discuss risk mitigation options for both early and late stage development programs.